To study the effect of TTK inhibition on non-dividing cells, that at the same time are relevant for cancer, we determined the effect of NTRC 0066-0 treatment on blood cell samples from ten different pediatric T-cell acute lymphoblastic leukemia (T-ALL) patients (Table 3). Here, TTK is linked to cancer.